The Quality of Reporting Harms-Related Data in Clinical Trials of Adjuvant Trastuzumab in Early-Stage Breast Cancer Treatment
Crossref DOI link: https://doi.org/10.1177/2168479013509383
Published Online: 2014-12-30
Published Print: 2014-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mahinbakht, Ali
Lavasani, Sayeh M.
Guirguis, Micheal
Text and Data Mining valid from 2014-05-01
Article History
Received: 18 July 2013
Accepted: 24 September 2013
First Online: 30 December 2014